Zepp Health Corporation
ZEPP · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $539,565 | $427,075 | $279,887 | $433,029 |
| % Growth | 26.3% | 52.6% | -35.4% | – |
| Cost of Goods Sold | $333,653 | $272,574 | $175,585 | $273,547 |
| Gross Profit | $205,912 | $154,501 | $104,301 | $159,482 |
| % Margin | 38.2% | 36.2% | 37.3% | 36.8% |
| R&D Expenses | $76,903 | $80,209 | $89,892 | $80,443 |
| G&A Expenses | $49,807 | $31,407 | $0 | $0 |
| SG&A Expenses | $135,302 | $118,145 | $147,863 | $144,042 |
| Sales & Mktg Exp. | $85,496 | $86,325 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $212,205 | $198,354 | $237,755 | $224,485 |
| Operating Income | -$6,293 | -$43,853 | -$133,454 | -$65,003 |
| % Margin | -1.2% | -10.3% | -47.7% | -15% |
| Other Income/Exp. Net | -$4,378 | -$10,050 | -$9,122 | -$104,646 |
| Pre-Tax Income | -$10,672 | -$53,904 | -$142,576 | -$169,649 |
| Tax Expense | $833 | $1,740 | $799 | $98,719 |
| Net Income | -$11,505 | -$55,644 | -$143,375 | -$268,550 |
| % Margin | -2.1% | -13% | -51.2% | -62% |
| EPS | -2.92 | -14 | -37.28 | -66.96 |
| % Growth | 79.1% | 62.4% | 44.3% | – |
| EPS Diluted | -4.56 | -14 | -35.76 | -66.96 |
| Weighted Avg Shares Out | 3,962 | 3,962 | 3,856 | 4,045 |
| Weighted Avg Shares Out Dil | 3,955 | 3,962 | 4,007 | 4,045 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2,121 | $4,220 | $5,607 |
| Interest Expense | $8,187 | $8,950 | $9,863 | $10,524 |
| Depreciation & Amortization | $8,929 | $5,111 | $0 | $4,124 |
| EBITDA | $6,445 | -$36,197 | -$130,113 | -$134,275 |
| % Margin | 1.2% | -8.5% | -46.5% | -31% |